Howard Weisman
Chief Executive Officer chez PAXMEDICA, INC.
Fortune : 17 721 $ au 31/03/2024
Profil
Howard J.
Weisman was the founder of ESP Pharma, Inc. (founded in 2002) where he served as President, Chief Operating Officer & Director from 2002 to 2005.
He was also the founder of EKR Therapeutics, Inc. (founded in 2005) where he was President & Chief Executive Officer from 2009 to 2010.
Additionally, he is the founder of ESP Equity Partners LLC (founded in 2005) and currently holds the position of General Partner since 2011.
In 2014, he founded Sofregen Medical, Inc. where he served as Executive Chairman until 2019.
Mr. Weisman's current job(s) include being Chairman, President & Chief Executive Officer at PaxMedica, Inc. since 2020 and Director at Promedior, Inc. since 2013.
His former job(s) include being President, Chief Executive Officer & Director at YourBio Health, Inc. from 2012 to 2018.
He also held positions at Parke, Davis & Co. LLC as Senior Director-Diabetes Marketing, Merck & Co., Inc. as Principal, and served as an Advisor at Roxiticus Ventures LLC.
In terms of education, Mr. Weisman attended Rutgers State University of New Jersey for his undergraduate degree and Princeton University for his graduate degree.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PAXMEDICA, INC.
0,47% | 12/03/2024 | 34 748 ( 0,47% ) | 17 721 $ | 31/03/2024 |
Postes actifs de Howard Weisman
| Sociétés | Poste | Début |
|---|---|---|
| PAXMEDICA, INC. | Chief Executive Officer | 04/03/2020 |
ESP Equity Partners LLC
 ESP Equity Partners LLC Investment ManagersFinance Founded by in 2005 by Howard Weisman, S. Douglas Sheldon and Dr. Jeffery Z. Li, ESP Equity Partners (ESP) is a private equity firm located in Cedar Knolls, New Jersey with additional offices in Miami and Beijing. | Founder | 03/09/2009 |
Promedior, Inc.
 Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Director/Board Member | 19/06/2013 |
Anciens postes connus de Howard Weisman
| Sociétés | Poste | Fin |
|---|---|---|
Sofregen Medical, Inc.
 Sofregen Medical, Inc. BiotechnologyHealth Technology Sofregen Medical, Inc. develops innovative silk-based solutions for soft tissue defects. Its products: SERI silk derived surgical scaffold is knitted scaffold made from ultra-pure, sterile, silk-derived bioprotein that facilitates neovascularization and native tissue regeneration over time and Sofregen technology a silk derived material for medical application. The company was founded by Anh Hoang and Howard J. Weisman on May 19, 2014 and is headquartered in Cambridge, MA. | Founder | 01/09/2019 |
YourBio Health, Inc.
 YourBio Health, Inc. Electronic Equipment/InstrumentsElectronic Technology YourBio Health, Inc. develops health monitoring products. It is developing an array of products based on the company's proprietary TAP? (Touch Activated Phlebotomy) painless blood collection platform. The company was founded by Richard Rox Anderson, Joerg Lahann, Robert S. Langer Jr., Douglas A. Levinson and Samir Mitragotri in 2008 and is headquartered in Medford, MA. | Chief Executive Officer | 01/01/2018 |
EKR Therapeutics, Inc.
 EKR Therapeutics, Inc. Hospital/Nursing ManagementHealth Services EKR Therapeutics, Inc. is a specialty pharmaceutical company focused on acquiring, developing and maximizing the potential utility of critical-care hospital products offering broader therapeutic options and greater control to improve in-patient care, speed recovery, and achieve optimal outcomes. Backed by the strength of its award winning management team, the dedication of its field force of product specialists and its commitment to excellence in customer service and medical education, EKR has been organized to be a class leader in commercializing products to address unmet and under-satisfied medical needs or to otherwise enhance the therapeutic value of acute-care products. | Chief Executive Officer | 03/03/2010 |
ESP Pharma, Inc.
 ESP Pharma, Inc. Pharmaceuticals: MajorHealth Technology ESP Pharma, Inc. produces pharmaceutical products. The company used to produce drug for acute-care hospital use and these drugs include therapeutics for high blood pressure and angina; one product, IV Busulfex, is used to prepare myelogenous for leukemia patients for bone marrow transplants. The company formulates its products to be delivered intravenously or by injection when oral administration is impossible. The company was founded in April, 2002 and was headquartered in Edison, NJ | Founder | 01/01/2005 |
| Parke, Davis & Co. LLC | Sales & Marketing | - |
Formation de Howard Weisman
| Rutgers State University of New Jersey | Undergraduate Degree |
| Princeton University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| PAXMEDICA, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
ESP Pharma, Inc.
ESP Pharma, Inc. Pharmaceuticals: MajorHealth Technology ESP Pharma, Inc. produces pharmaceutical products. The company used to produce drug for acute-care hospital use and these drugs include therapeutics for high blood pressure and angina; one product, IV Busulfex, is used to prepare myelogenous for leukemia patients for bone marrow transplants. The company formulates its products to be delivered intravenously or by injection when oral administration is impossible. The company was founded in April, 2002 and was headquartered in Edison, NJ | Health Technology |
EKR Therapeutics, Inc.
EKR Therapeutics, Inc. Hospital/Nursing ManagementHealth Services EKR Therapeutics, Inc. is a specialty pharmaceutical company focused on acquiring, developing and maximizing the potential utility of critical-care hospital products offering broader therapeutic options and greater control to improve in-patient care, speed recovery, and achieve optimal outcomes. Backed by the strength of its award winning management team, the dedication of its field force of product specialists and its commitment to excellence in customer service and medical education, EKR has been organized to be a class leader in commercializing products to address unmet and under-satisfied medical needs or to otherwise enhance the therapeutic value of acute-care products. | Health Services |
YourBio Health, Inc.
YourBio Health, Inc. Electronic Equipment/InstrumentsElectronic Technology YourBio Health, Inc. develops health monitoring products. It is developing an array of products based on the company's proprietary TAP? (Touch Activated Phlebotomy) painless blood collection platform. The company was founded by Richard Rox Anderson, Joerg Lahann, Robert S. Langer Jr., Douglas A. Levinson and Samir Mitragotri in 2008 and is headquartered in Medford, MA. | Electronic Technology |
Promedior, Inc.
Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Health Technology |
ESP Equity Partners LLC
ESP Equity Partners LLC Investment ManagersFinance Founded by in 2005 by Howard Weisman, S. Douglas Sheldon and Dr. Jeffery Z. Li, ESP Equity Partners (ESP) is a private equity firm located in Cedar Knolls, New Jersey with additional offices in Miami and Beijing. | Finance |
| Parke, Davis & Co. LLC | |
Roxiticus Ventures LLC
 Roxiticus Ventures LLC Investment ManagersFinance Founded in 2001 by Richard DeSimone, Roxiticus Ventures LLC is a venture capital firm located in Cedar Knolls, New Jersey. | Finance |
Sofregen Medical, Inc.
Sofregen Medical, Inc. BiotechnologyHealth Technology Sofregen Medical, Inc. develops innovative silk-based solutions for soft tissue defects. Its products: SERI silk derived surgical scaffold is knitted scaffold made from ultra-pure, sterile, silk-derived bioprotein that facilitates neovascularization and native tissue regeneration over time and Sofregen technology a silk derived material for medical application. The company was founded by Anh Hoang and Howard J. Weisman on May 19, 2014 and is headquartered in Cambridge, MA. | Health Technology |
